| Current Price | $53.37 | Mkt Cap | $8.5B |
|---|---|---|---|
| Open | $54.49 | P/E Ratio | 0.00 |
| Prev. Close | $53.66 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $53.15 - $54.50 | Volume | 684,251 |
| 52-Wk Range | $30.02 - $58.72 | Avg. Daily Vol. | 895,787 |
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
| Current Price | $53.37 | Mkt Cap | $8.5B |
|---|---|---|---|
| Open | $54.49 | P/E Ratio | 0.00 |
| Prev. Close | $53.66 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $53.15 - $54.50 | Volume | 684,251 |
| 52-Wk Range | $30.02 - $58.72 | Avg. Daily Vol. | 895,787 |
The best Bull and Bear pitches based on recency and number of recommendations.
Nuplazid is the first drug approved for the treatment of PD psychosis. This market represents a 2-3B peak in sales. If Pimavanserin successfully expands its label to Alzheimer psychosis, Alzheimer agitation, schizo IRAT, then you have a company with… More
This article does a good job of laying out the bear case: http://seekingalpha.com/article/4015176-acadias-nuplazid-blockbuster-drug-imaginedThe market may turn out to be smaller than expected, especially with the black box warning ("Side effects… More
Read the most recent pitches from players about ACAD.
Recs
swt99
(< 20)
Submitted: 10/8/2020 8:43:49 PM :
Start Price:
$41.45
NASDAQ:ACAD Score:
+18.04
I got this one cause it came highly recommended. only keep for a short time then sale. They predict that it may got high
Recs
pitbullsneedlove
(91.14)
Submitted: 8/15/2020 6:51:41 PM :
Start Price:
$39.85
NASDAQ:ACAD Score:
+21.88
It’s already profitable and I see a lot of uses for its medicine.
Recs
LifeScientist
(81.95)
Submitted: 7/2/2020 3:08:37 PM :
Start Price:
$52.08
NASDAQ:ACAD Score:
-18.24
The principal pipieline drug Nuplazid seeking fda approval is already market for Parkinson’s patients. Wow, my own Mom could benefit! ....we’ve been seeking a drug that would help her hallucinations w dementia. sNDA on dementia now....hope it works and is covered by insurance!
Find the members with the highest scoring picks in ACAD.
jamrod02 (61.54) Score: +6,628.27
The Score Leader is the player with the highest score across all their picks in ACAD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jamrod02 | 61.54 | 12/20/2010 |
|
5Y | $0.77 | +6,832.07% | +203.79% | +6,628.27 | 0 Comment | |
| noobtery | 64.19 | 10/28/2010 |
|
5Y | $0.83 | +6,330.12% | +218.56% | +6,111.56 | 0 Comment | |
| Hornet41 | 60.84 | 12/22/2010 |
|
5Y | $0.90 | +5,829.34% | +201.76% | +5,627.58 | 0 Comment | |
| Ruckwerts | 52.28 | 12/1/2011 |
|
3Y | $0.93 | +5,638.71% | +203.48% | +5,435.23 | 0 Comment | |
| dsherid2 | 56.15 | 11/30/2011 |
|
1Y | $1.03 | +5,082.06% | +204.77% | +4,877.28 | 0 Comment | |
| Smog79 | < 20 | 8/12/2010 |
|
3W | $1.04 | +5,031.73% | +248.63% | +4,783.10 | 0 Comment | |
| drmanand | 63.45 | 7/14/2010 |
|
1Y | $1.11 | +4,708.97% | +246.40% | +4,462.57 | 1 Comment | |
| smallandmidcap | 88.93 | 8/10/2010 |
|
5Y | $1.13 | +4,623.01% | +237.99% | +4,385.02 | 0 Comment | |
| dmkj50 | 21.45 | 10/27/2011 |
|
5Y | $1.17 | +4,461.15% | +195.98% | +4,265.17 | 0 Comment | |
| tappo3833 | 88.97 | 1/3/2011 |
|
1Y | $1.19 | +4,384.87% | +198.83% | +4,186.04 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
